PubMed COVID-19 Clinical Care

Common Seasonal Pathogens and Epidemiology of Henoch-Schönlein Purpura Among Children

Friday, April 05, 2024 - 4:00 AM

CONCLUSIONS AND RELEVANCE: This study found that significant changes in the incidence of HSP simultaneously with major shifts in circulating pathogens after NPIs for the COVID-19 pandemic indicated that approximately 60% of HSP incidence was

Challenging anticoagulation therapy for multiple primary malignant tumors combined with thrombosis: A case report and review of literature

Friday, April 05, 2024 - 4:00 AM

CONCLUSION: Anticoagulant prophylaxis should be promptly initiated in cases of high-risk thrombosis. Individualized anticoagulation therapy is required for complex thrombosis.

Changes in diagnostic patterns and resource utilisation in Swiss adult ICUs during the first two COVID-19 waves: an exploratory study

Friday, April 05, 2024 - 4:00 AM

CONCLUSIONS: Based on a comprehensive national data set, our report describes the profound changes triggered by COVID-19 over one year in Swiss ICUs. We observed an overall decrease in admissions and a shift in admission types, with fewer planned

Comparing effectiveness of residential versus intensive virtual treatment for veterans with posttraumatic stress disorder

Thursday, April 04, 2024 - 4:00 AM

CONCLUSION: These analyses suggest that intensive virtual treatment has similar effectiveness to residential treatment for PTSD. This supports the development of intensive virtual interventions as viable alternatives to residential treatments and a

Community Partnership to Co-Develop an Intervention to Promote Equitable Uptake of the COVID-19 Vaccine Among Pediatric Populations

Thursday, April 04, 2024 - 4:00 AM

CONCLUSIONS: Engaging community and family partners led to the co-development of culturally- and locally-tailored strategies to promote dialogue and shared decision-making about the COVID-19 vaccine. This process can be used to codevelop

Correction: Risk of transmission of SARS-CoV-2 on international flights, a retrospective cohort study using national surveillance data in England

Thursday, April 04, 2024 - 4:00 AM

No abstract

COVID-19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy

Thursday, April 04, 2024 - 4:00 AM

Coronavirus-19 (COVID-19) mortality rates among haemopoietic stem cell transplant (HSCT) patients are high, ranging between 20% and 40%. We prospectively evaluated the mortality outcomes of COVID-19 in Western Australian HSCT patients. A total of 32

Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study

Thursday, April 04, 2024 - 4:00 AM

CONCLUSIONS: Risk of COVID-19 hospitalisation in sotrovimab-treated patients aged ≥65 years and with renal disease was significantly lower compared with untreated patients. Overall, risk of hospitalisation was also lower for sotrovimab-treated

Care navigation addresses issues of tele-mental health acceptability and uptake in rural and remote Australian communities

Thursday, April 04, 2024 - 4:00 AM

CONCLUSION: Attitudes towards telehealth have changed during the COVID-19 pandemic, however although the need exists, barriers remain to uptake. Telehealth alone is not enough. Coupling telehealth with other supports such as care navigation improves

Cell immunity to SARS-CoV-2 after natural infection and/or different vaccination regimens

Thursday, April 04, 2024 - 4:00 AM

CONCLUSION: Heterologous vaccination (AZ/PZ) elicited the strongest immunity among the two-dose vaccination regimens. The immunity offered by the third-booster dose of SARS-CoV-2 vaccine depends not only on the type of vaccine administered but also